MATRIARCH OF MODERN CANCER GENETICS Contd…
Janet Rowley unlocked the Rosetta stone to modern understanding of cancer genetics. Her work initially met with lots of skepticism as chromosomal abnormalities were then considered to be effect of disease rather than the cause. However, by 1980s, each of the abnormalities had been molecularly characterized which revealed that translocations create fusion proteins that drive cell growth. Soon, scientists identified many chromosomal translocations in other cancers. Her discoveries was very useful as it led to the greater understanding of the molecular pathogenesis of certain cancers and led to breakthrough therapies like using Imatinib in Chronic myeloid leukemia and high-dose retinoic acid in treatment of acute promyelocytic leukemia. She went on to publish over 500 journal articles. She spent her entire career at the University of Chicago. In 1962, she joined as a research associate in the Department of Hematology. She became an associate professor in 1969 and a professor in 197